The largest database of trusted experimental protocols

Gen5 plate reader

Manufactured by Agilent Technologies
Sourced in United States

The Gen5 plate reader is a versatile instrument designed for optical detection and analysis in a multiwell plate format. It is capable of performing a variety of detection modes, including absorbance, fluorescence, and luminescence. The Gen5 plate reader is suitable for a wide range of applications in life science research and drug discovery.

Automatically generated - may contain errors

20 protocols using gen5 plate reader

1

ELISA for COVID-19 Protein Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The spike protein level on exosomes was measured by an ELISA using precoated ELISA plates (catalog number ELV-COVID19S1; RayBiotech), according to the manufacturer’s instructions, at RT. The nucleocapsid level on exosomes was measured by an ELISA using precoated ELISA plates (Legend Max SARS-CoV2 nucleocapsid protein ELISA kit, catalog number 448007; BioLegend), according to the manufacturer’s instructions, at RT. Briefly, samples and standards were loaded onto the precoated plate and incubated for 2 to 2.5 h at RT on a shaker (200 rpm). Plates were washed and incubated with a biotin-conjugated detection antibody for an hour at RT, followed by a 45-min incubation in a streptavidin solution. After washes, plates were developed using the TMB substrate. After a 30-min incubation, the reaction was stopped by the addition of a stop solution, and the absorbance at 450 nm was recorded using a BioTek Gen5 plate reader (Agilent). For nucleocapsid, after a 10-min incubation with the TMB substrate, the absorbance was recorded at 450 nm and 570 nm. For analysis, the absorbance at 570 nm can be subtracted from the absorbance at 450 nm, and the OD can be used to build a standard curve.
+ Open protocol
+ Expand
2

ELISA for COVID-19 Protein Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The spike protein level on exosomes was measured by an ELISA using precoated ELISA plates (catalog number ELV-COVID19S1; RayBiotech), according to the manufacturer’s instructions, at RT. The nucleocapsid level on exosomes was measured by an ELISA using precoated ELISA plates (Legend Max SARS-CoV2 nucleocapsid protein ELISA kit, catalog number 448007; BioLegend), according to the manufacturer’s instructions, at RT. Briefly, samples and standards were loaded onto the precoated plate and incubated for 2 to 2.5 h at RT on a shaker (200 rpm). Plates were washed and incubated with a biotin-conjugated detection antibody for an hour at RT, followed by a 45-min incubation in a streptavidin solution. After washes, plates were developed using the TMB substrate. After a 30-min incubation, the reaction was stopped by the addition of a stop solution, and the absorbance at 450 nm was recorded using a BioTek Gen5 plate reader (Agilent). For nucleocapsid, after a 10-min incubation with the TMB substrate, the absorbance was recorded at 450 nm and 570 nm. For analysis, the absorbance at 570 nm can be subtracted from the absorbance at 450 nm, and the OD can be used to build a standard curve.
+ Open protocol
+ Expand
3

Phage Cocktail Inhibits ESBL/AmpC E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
Growth inhibition effect of ESBL/AmpC E. coli strains was performed following previous described method.59 Firstly, ESBL/AmpC E. coli strains ESBL102 and ESBL145 was chosen as hosts because of their genetic diversity. Secondly, Phages AV114, AV118 and AV125 were chosen as phage cocktail against ESBL102 whereas phages AV110, AV111, AV114 and AV125 were combined against ESBL145. Both single phages and the cocktail were evaluated for their growth inhibition ability against the strains. A single colony of each strain were inoculated in 5 mL LB media and incubated overnight at 37°C and 180 rpm. The following morning, the cultures were diluted to 1∗10ˆ8 CFU/mL and 100 μL of the culture was added to 96 wells plates (TPP). Afterwards, the phages (MOI of 10) were added to the samples and the plates were incubated in Gen5 plate reader (Agilent BioTek) for 24 hours at 37°C and OD600 values were determinate every 15 minutes. ESBL102 and ESBL145 without phages were used as negative controls. The growth inhibition assay was done in three triplicates and the standard deviations were calculated in GraphPad Prism9 (version 9.5.0).
+ Open protocol
+ Expand
4

Bacterial Growth Assay with TNFR2 Agonist

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial broth cultures of USA300 LAC::lux or Xen41 were prepared as described above. Overnight cultures were diluted 1:50 in their respective growth media. Next, 50 μl of bacterial cultures was incubated with either 50 μl of vehicle (sterile PBS) or 50 μl of TNFR2 agonist to reach final concentrations of 80, 160, and 320 μg/ml in a total volume of 100 μl. The bacterial growth (OD600) was measured at 20-min intervals in triplicate for 10 hours while shaking at 282 cpm (counts per minute) at 37°C in a Gen5 plate reader (BioTek).
+ Open protocol
+ Expand
5

Quantifying HaCaT Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation capacity was evaluated using the cell counting kit-8 (CCK-8) assay (GK10001, GLPBIO, Montclair, USA). HaCaT cell suspensions (5 × 103/well, 100 μl) were seeded into 96-well plates. Following incubation for the indicated time period, 10 μl of CCK-8 solution was added directly to each well and incubated for 2 h at 37°C. Absorbance was measured at 450 nm using a Gen5 plate reader (BioTek, Winooski, VT, USA). Cell confluence (percentage) was observed using IncuCyte ZOOM™ (Essen Bioscience, MI, USA); this instrument enables observation of cell growth, behavior and morphology. Moreover, its software can generate a proliferation growth curve of cells.
+ Open protocol
+ Expand
6

Antibacterial Activity Screening of Products

Check if the same lab product or an alternative is used in the 5 most similar protocols
In a 96-well microplate, the following were added to each well: 75 µL fresh nutrient broth, 50 µL test product, 25 µL E. coli broth culture at 0.5 OD, adapted from Kalyoussef et al.21 (link). Each of the seven E. coli strains were tested against the five products and four controls (Table 1). Corresponding control wells, which served as blanks in calculations of optical density at 600 nm (OD600), were created for every test condition containing 25 µL of nutrient broth medium instead of 25 µL of bacterial broth culture. Plates were incubated at 37 °C with agitation for 6 hours. OD600 measurements were taken at every 2 hours with a Biotek Gen5 plate reader (Burlington, VT).
+ Open protocol
+ Expand
7

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Broth microdilution assays were used to determine the minimum inhibitory concentration (MIC) of tetracycline, amikacin, and five different beta-lactam antibiotics (Cephalothin, Cefoxitin, Cefotaxime, Cefepime, and Imipenem). The beta-lactam drugs were chosen as representative of different generations of cephalosporin antibiotics and a carbapenem, respectively. Ninety-six well plates were seeded with LB broth containing 103 CFU/mL starting concentration of bacteria. Antibiotics were added in a two- fold serial dilution starting at 500 μg/mL. Cultures were incubated overnight, and growth was measured at OD600 using a Biotek Gen5 plate reader (Winooski, VT, USA). Wells containing only LB and bacteria were used as controls for normal growth. The MIC breakpoint was determined as the lowest antibiotic concentration at no increase in optical density over a broth; only control was detected. All samples were tested in triplicate.
+ Open protocol
+ Expand
8

Intratumoral IFN-γ Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Untreated and irradiated MC38 tumors treated with human equivalent dose dexamethasone or vehicle control were harvested at day nine post tumor implantation (two days post radiotherapy). Tumors were suspended in lysis buffer 11 solution at 400 mg/mL and snap frozen in liquid nitrogen. Snap frozen tumors were thawed on ice and homogenized for 30 seconds on ice using a Bio-Gen PRO200 Homogenizer (PRO Scientific), centrifuged to remove cellular debris, and supernatants were used in bicinchoninic acid assays (Thermo Scientific) and IFN-γ ELISAs (Invitrogen) according to the manufacturers’ instructions. Intratumoral IFN-γ concentration was calculated by dividing pg IFN-γ as determined by ELISA by mg total protein as determined by BCA. All BCA and ELISA sample plates were read on a Gen5 plate reader (BioTek).
+ Open protocol
+ Expand
9

Intratumoral IFN-γ Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
MC38 and B16F10 tumors harvested at day nine post tumor implantation were suspended in lysis buffer 11 solution at 400 mg/mL and snap frozen in liquid nitrogen. Samples were then thawed on ice and homogenized for 30 seconds on ice using a Bio-Gen PRO200 Homogenizer (PRO Scientific, Oxford, CT). Tumor homogenate was centrifuged to remove cellular debris, and supernatants were used in bicinchoninic acid assays (BCA, Thermo Scientific, Waltham, MA) and IFN-γ ELISAs (Invitrogen, Waltham, MA) according to the manufacturers’ instructions. Intratumoral IFN-γ concentration was calculated by dividing pg IFN-γ by mg total protein. All BCA and ELISA sample plates were read on a Gen5 plate reader (BioTek, Winooski, VT).
+ Open protocol
+ Expand
10

Alkaline Phosphatase Activity in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the time of confluence, primary suture derived cells, BMSCs, C2C12s, and MC3T3-E1s were seeded at a density of 4,000 cells per 0.32 cm2 well for alkaline phosphatase (ALP) assays (Sigma-Aldrich, USA). Comparison was made between control and thyroxine treated cells by kinetics of absorbance read at 405 nm on a Gen5 plate reader (BioTek, Winooski, VT, USA). ALP assay was repeated for MC3T3-E1 pre-osteoblasts with media as above supplemented with 0, 250, or 1000ng/ml of rhSFRP4 (R&D Systems, Minneapolis, MN). All assays were conducted after 7 days in culture.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!